T.Man Pharmaceutical PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	545.8	448.39	348.04	307.17	22.19	66.9
Cash & Short-Term Investments	545.8	448.39	348.04	307.17	22.19	66.9
Cash Growth	278.65%	28.83%	13.30%	1284.31%	-66.83%	-
Accounts Receivable	574.14	596.4	577.79	507.27	256.08	206.77
Other Receivables	89.12	17.53	38.75	21.37	23.94	8.08
Receivables	663.27	613.93	616.54	528.64	280.02	214.84
Inventory	496.45	541.45	481.82	357.96	308.9	410.68
Other Current Assets	252.44	470.32	4.99	32.2	4.21	7.25
Total Current Assets	1,958	2,074	1,451	1,226	615.32	699.66
Property, Plant & Equipment	1,133	1,143	1,048	930.41	742.63	724.85
Long-Term Investments	-	-	-	-	-	5
Other Intangible Assets	36.33	33.84	25.69	12.56	1.23	0.27
Long-Term Deferred Tax Assets	38.13	34.25	38.89	40.69	-	-
Other Long-Term Assets	283.78	170.23	63.18	68.24	199.02	171.13
Total Assets	3,449	3,456	2,627	2,278	1,558	1,601
Accounts Payable	333.43	370.1	331.91	333.08	192.3	120.03
Short-Term Debt	945	1,080	503.43	535	614.57	805.17
Current Portion of Long-Term Debt	-	-	33.08	22	16.01	48.34
Current Portion of Leases	5.11	5.66	7.08	4.55	3.01	0.64
Current Income Taxes Payable	42.69	27.53	22.63	110.2	11.34	4.65
Current Unearned Revenue	83.41	72.01	100.29	73.8	-	-
Other Current Liabilities	10.43	20.79	23.98	20.46	59.06	21.2
Total Current Liabilities	1,420	1,576	1,022	1,099	896.29	1,000
Long-Term Debt	-	-	-	33.08	8.33	24.36
Long-Term Leases	63.23	64.95	47.89	44.36	28.28	24.7
Other Long-Term Liabilities	0.96	0.58	2.39	26.93	25.89	14.86
Total Liabilities	1,531	1,686	1,108	1,236	987	1,086
Common Stock	300	300	246.43	187.3	187.3	50
Additional Paid-In Capital	1,394	1,394	305.88	305.88	305.88	-
Retained Earnings	476.5	327.82	993.46	575.48	103.91	98.34
Comprehensive Income & Other	-251.78	-251.78	-26.37	-26.37	-24.95	366.47
Total Common Equity	1,919	1,770	1,519	1,042	572.14	514.81
Minority Interest	-	-0	0	0	-0.93	-
Shareholders' Equity	1,919	1,770	1,519	1,042	571.21	514.81
Total Liabilities & Equity	3,449	3,456	2,627	2,278	1,558	1,601
Total Debt	1,013	1,151	591.48	638.99	670.21	903.21
Net Cash (Debt)	-467.53	-702.22	-243.44	-331.82	-648.02	-836.31
Net Cash Per Share	-1.23	-2.04	-0.88	-1.33	-8.98	-12.54
Filing Date Shares Outstanding	400	400	328.57	249.73	249.73	66.67
Total Common Shares Outstanding	400	400	328.57	249.73	249.73	66.67
Working Capital	537.89	497.98	428.98	126.89	-280.97	-300.37
Book Value Per Share	4.80	4.42	4.62	4.17	2.29	7.72
Tangible Book Value	1,882	1,736	1,494	1,030	570.91	514.54
Tangible Book Value Per Share	4.71	4.34	4.55	4.12	2.29	7.72
Land	-	124.07	108.09	94.16	64.95	64.95
Buildings	-	1,104	1,014	897.56	713.66	672.08
Machinery	-	609.53	548.56	448.73	415.39	378.1
Construction In Progress	-	81.94	68.6	93.44	82.16	75.3

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.